Effect of Erenumab on Absenteeism and Presenteeism in Patients with Episodic and Chronic Migraine in Actual Clinical Practice in Japan: A Retrospective Observational Study

被引：0
|
作者：
Sadamoto, Yasutaka [1 ]
机构：
[1] Takanoko Hosp, Matsuyama, Ehime, Japan
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [21] Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study
    Cainazzo, Maria Michela
    Baraldi, Carlo
    Ferrari, Anna
    Lo Castro, Flavia
    Pani, Luca
    Guerzoni, Simona
    NEUROLOGICAL SCIENCES, 2021, 42 (10) : 4193 - 4202
  • [22] Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials
    Stewart J Tepper
    Messoud Ashina
    Uwe Reuter
    Yngve Hallström
    Gregor Broessner
    Jo H Bonner
    Hernan Picard
    Sunfa Cheng
    Denise E Chou
    Feng Zhang
    Jan Klatt
    Daniel D Mikol
    The Journal of Headache and Pain, 2021, 22
  • [23] Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials
    Tepper, Stewart J.
    Ashina, Messoud
    Reuter, Uwe
    Hallstroem, Yngve
    Broessner, Gregor
    Bonner, Jo H.
    Picard, Hernan
    Cheng, Sunfa
    Chou, Denise E.
    Zhang, Feng
    Klatt, Jan
    Mikol, Daniel D.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):
  • [24] Effect of Erenumab on Patient-reported Outcomes in Patients with Episodic Migraine from Asia, the Middle East and Latin America: The EMPOwER Study
    Wang, Shuu-Jiun
    Roxas, Artemio A., Jr.
    Saravia, Bibiana
    Kim, Byung-Kun
    Chowdhury, Debashish
    Riachi, Naji
    Tai, Mei-Ling S.
    Tanprawate, Surat
    Ngoc, Tai T.
    Zhao, Yi Jing J.
    Su, Wendy
    Wen, Shihua
    Mondal, Subhayan
    Ecochard, Laurent
    Arkuszewski, Michal
    Chehrenama, Mahan
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 63 - 65
  • [25] No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational study
    Florescu, Anna Maria
    Lannov, Laerke Vig
    Younis, Samaira
    Cullum, Christopher Kjaer
    Chaudhry, Basit Ali
    Do, Thien Phu
    Amin, Faisal Mohammad
    CEPHALALGIA, 2024, 44 (01) : 3331024231222915
  • [26] A retrospective observational study on biological drug treatment in a daily practice serving patients with psoriasis in Japan
    Ohata, Chika
    Ohyama, Bungo
    Nanri, Aya
    Shintani, Takako
    Nakama, Takekuni
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2019, 30 (01) : 45 - 48
  • [27] Characterisation of prescription patterns in episodic and chronic migraine patients starting treatment in a real life setting with erenumab in Germany (SPECTRE) - A real world evidence study
    Gaul, C.
    Koch, M.
    Baufeld, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 154 - 154
  • [28] BASELINE DATA OF A REAL-WORLD-EVIDENCE-STUDY CHARACTERIZING PRESCRIPTION PATTERNS IN EPISODIC AND CHRONIC MIGRAINE PATIENTS STARTING TREATMENT WITH ERENUMAB IN GERMANY (SPECTRE)
    Gaul, Charly
    Koch, Mirja
    Baufeld, Caroline
    CEPHALALGIA, 2020, 40 : 67 - 67
  • [29] Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful: results from the LIBERTY study
    Lanteri-Minet, Michel
    Goadsby, Peter J.
    Reuter, Uwe
    Wen, Shihua
    Hours-Zesiger, Peggy
    Ferrari, Michel D.
    Klatt, Jan
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 (05): : 466 - 472
  • [30] Psoriasis management in actual clinical practice: a 6-year retrospective study of 845 patients
    Uysal, Pinar Incel
    Sahin, Buket
    Yalcin, Basak
    Alkan, Afra
    Yuksel, Selcen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2018, 29 (08) : 797 - 801
12345